Content Preview
Newsday/Optimum Online® subscribers click here for full access
Not a Newsday or Optimum Online® subscriber? Click here
Amylin signs weight-loss drug deal with Takeda
NEW YORK (AP) — Amylin Pharmaceuticals Inc. says it could potentially receive more than $1 billion from a partnership with Japan's Takeda Pharmaceutical Co. on potential weight-loss treatments.
Company shares climbed nearly 10 percent in trading Monday, despite an announcement that government regulators strengthened warning labels on company's diabetes treatment Byetta.
The Food and...
newsday.com is now available at no charge to Newsday and Optimum Online® subscribers. To continue reading, please log in or register now.
-
Already
registered on
newsday.com?
log in -
Already a subscriber
to Newsday or
Optimum Online®?
get access -
Not a Newsday
or Optimum Online®
subscriber?
click here
